Bausch Health Companies | VRX - SCHULD

Aktienkurs
7.89
Täglich Wechseln
0.12 1.54%
Monatlich
14.68%
Jährlich
31.28%
Q2 Prognose
7.59




SCHULD Veränderung Datum
Amgen USD 54.59B 1.62B 2025-09
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bausch Health Companies USD 21.04B 696M 2025-09
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.36M 247K 2025-09
Danaher USD 18.42B 1.56B 2025-12
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.04B 1.7M 2025-09
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09
Zoetis USD 7.27B 482M 2025-09